Using a systems genetics approach, a new study identifies genetic variants and proteins associated with plasma and hepatic lipid abundance and hepatic lipotoxicity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Moore, J. B. Proc. Nutr. Soc. https://doi.org/10.1017/S0029665119000570 (2019).
Parker, B. L. et al. Nature 567, 187–193 (2019).
Spanos, C. et al. Proteome Sci. 16, 4 (2018).
Xue, M. et al. Diabetes 65, 2282–2294 (2016).
Kaneko, T. et al. Cell 137, 914–925 (2009).
Baumeier, C. et al. Biochim. Biophys. Acta 1851, 566–576 (2015).
Stanojevic, V., Yao, K. M. & Thomas, M. K. Mol. Cell. Endocrinol. 237, 67–74 (2005).
Mardinoglu, A. et al. Nat. Commun. 5, 3083 (2014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moore, J.B., Thorne, J.L. Predicting and reducing hepatic lipotoxicity in non-alcoholic fatty liver disease. Lab Anim 48, 143–144 (2019). https://doi.org/10.1038/s41684-019-0291-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41684-019-0291-0